The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Venetoclax activity in CLL patients who have relapsed after or are refractory to ibrutinib or idelalisib.
 
Jeffrey Alan Jones
Consulting or Advisory Role - Genentech/Abbvie; Gilead Sciences; Pharmacyclics
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); Genentech/Abbvie (Inst); Gilead Sciences (Inst); Janssen (Inst); MedImmune (Inst); Pharmacyclics (Inst)
 
William G. Wierda
Speakers' Bureau - Genentech
Research Funding - Abbvie; Genentech
 
Michael Y. Choi
Consulting or Advisory Role - Abbvie; Gilead Sciences
Speakers' Bureau - Gilead Sciences
Research Funding - Abbvie (Inst)
 
Matthew Steven Davids
Consulting or Advisory Role - Abbvie; Genentech; Infinity Pharmaceuticals; Janssen
Research Funding - Infinity Pharmaceuticals (Inst); Pharmacyclics (Inst); TG Therapeutics (Inst)
 
Bruce D. Cheson
Consulting or Advisory Role - Abbvie; Gilead Sciences; Pharmacyclics; Roche/Genentech
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); Gilead Sciences (Inst); Pharmacyclics (Inst); Roche (Inst)
 
Richard R. Furman
Honoraria - Genentech/Roche; Gilead Sciences; Janssen; Pharmacyclics
Consulting or Advisory Role - Genentech/Roche; Gilead Sciences; Janssen Biotech; Pharmacyclics
Speakers' Bureau - Genentech; Janssen; Pharmacyclics
Research Funding - Acerta Pharma
Travel, Accommodations, Expenses - Genentech/Roche; Gilead Sciences; Janssen; Pharmacyclics
 
Nicole Lamanna
Consulting or Advisory Role - Abbvie; Celgene; Genentech; pharmacyclics; ProNAi
Research Funding - Abbvie (Inst); Genentech/Abbvie (Inst); Gilead Sciences (Inst); Infinity Pharmaceuticals (Inst); ProNAi (Inst)
 
Paul M. Barr
Consulting or Advisory Role - Abbvie; Genentech; Pharmacyclics; Seagen
Research Funding - Pharmacyclics (Inst)
 
Herbert Aaron Eradat
Consulting or Advisory Role - Abbvie; Genentech; Gilead Sciences
Speakers' Bureau - Genentech; Gilead Sciences
 
Ahmad Sami Halwani
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Immune Design (Inst); Kyowa Hakko Kirin (Inst); Miragen (Inst); Seagen (Inst); Takeda (Inst)
 
Leonard T. Heffner
Research Funding - Abbvie (Inst); Pharmacyclics (Inst)
 
Brenda Chyla
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Ming Zhu
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Jalaja Potluri
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Maria E. Verdugo
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Rod Humerickhouse
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Anthony R. Mato
Consulting or Advisory Role - Abbvie; Janssen; Pharmacyclics
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); Gilead Sciences (Inst); Pharmacyclics (Inst); TG Therapeutics (Inst)
 
Steven Coutre
Stock and Other Ownership Interests - Pharmacyclics (I)
Honoraria - Gilead Sciences
Consulting or Advisory Role - Abbvie; Celgene; Genentech/Roche; Gilead Sciences; Janssen Oncology; Novartis; Pharmacyclics
Research Funding - Abbvie (Inst); Celgene (Inst); Gilead Sciences (Inst); Novartis (Inst); Pharmacyclics (Inst)
Travel, Accommodations, Expenses - abbvie; Celgene; Gilead Sciences; Janssen Oncology; Novartis; Pharmacyclics